EIC Summit 25 Networking Platform

2–3 Apr 2025 | Brussels, Belgium

Josune Ayo

CoFounder & CEO

Genbioma Aplicaciones S.L.

Navarra, Navarra, Spain

21 profile visitsEIC Beneficiary

Genbioma: Microbiome Science for Metabolic Disorders: Postbiotics for Diabetes & Obesity and cardiometabolic.

My organisation

Metabolic Health through Microbiome Science. Precision Postbiotics to prevent glucose metabolic disorders and improve human health. Our mission is simple: to improve people's health through microbiome products (probiotics and postbiotics). By targeting the gut microbiota with specific strains, we can regulate glucose and lipid metabolism to improve health (diabetes, obesity, hypercholesterolemia). The microbiome has countless applications in health. To this end, we have created a platform to develop natural and safe nutritional ingredients and supplements that regulate metabolism through the balance of the intestinal microbiota. Our cutting-edge technology and microbiome science are based on rapid detection of bacterial strains by using the C. elegans model to rapidly search for potential in health goals. Our first portfolio of microbiome solutions for people with type 2 diabetes (T2D), prediabetes (preD), and obesity. We use state-of-the-art metagenomic and metabolomic tools and our rapid bacterial strain detection platform in C. elegans to quickly search for health targets. By targeting the gut microbiota with specific postbiotic products, we can improve metabolic health and also help prevent and reverse disease progression Our business strategy is to operate within a B2B framework spanning the pharma and food sectors.
Read more

About me

Co-Founder, Investor and Managing Director at Genbioma.

Ph.D. in Food Sci and Tech, MSc Degree on Food Sci. & Tech and BSc Degree on Nutrition and Human Health.

Top 60 Women in AgriFood 2024 . EIC Women Leadership Programme 2023. +25 year in Healthy Foods Sector focused on international market. Member of National and European Technical Committees in Food&Health.Co-author of 30 scientific articles, 6 international patents +50 R&D projects +50 Conferences. h-index: 14

GENBIOMA: Probiota Pioneers 2022. Top 10 Global Nutritional Supplements Trends 2023. Top 10 International Next Wave of Startups of Microbiome Technology (2023).Top 101 Spanish startups (2024).

Microbiome Science for metabolic disorders in human health. Postbiotics (Microbiome based Products) for Diabetes related conditions (PreDiabetes, T2Diabetes) & Obesity. Solid scientific research on the Mechanism of Action. Metabolism & Gut Microbiota. Personalized and precision Microbiome-based products (Postbiotics) for the nutritional management of metabolic disorders. Focused on international market.

Social media

Skills

  • Biotech, Food and Health-related sectors
  • Microbiome based products
  • Investor
  • Management biotech startup
  • Probiotics¬Metabolism
  • Diabetes, Obesity, Dyslipemia

Interests

  • International market
  • Distribution Agreements
  • Food and Pharma sectors
  • Investment
  • R&D collaboration

Marketplace (6)